Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Oasmia enters license and distribution agreement with Orion for Paclical

Dec. 4, 2007

Celsion reports positive results from animal and stability studies of liposomal docetaxel

Dec. 3, 2007

MediGene and Celltrion sign agreement for anti-L1 monoclonal antibody for cancer

Dec. 3, 2007

Geron initiates phase I/II clinical trial of GRN-163L in multiple myeloma

Nov. 30, 2007

S*BIO initiates clinical development of SB-1317 as a therapy for acute leukemias

Nov. 30, 2007

Novel treatment options for cancer covered in recent patent literature

Nov. 30, 2007

Cyclacel presents an update on clinical development programs

Nov. 29, 2007

New agents with potential in the treatment of cancer disclosed in recent patent literature

Nov. 29, 2007

E.U. approves Tasigna for Ph+ CML patients with poor response to current therapy

Nov. 28, 2007

Kinex initiates phase I clinical trial of KX2-391 for advanced solid tumors and lymphoma

Nov. 28, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...